Internal Medicine, Medical Oncology · E Setauket, NY
NPI
1932195138
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
235 N Belle Mead Rd
E Setauket, NY, 11733
Phone (631) 751-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
86,972 services
Medicare patients, 2024
770
Average age 75
Drug cost, 2024
$8.3M
2,289 prescriptions
Company payments, 2025
$128
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gurmohan Syali was code J1439 (injection, ferric carboxymaltose, 1 mg), 24,000 times for 23 patients. In total Gurmohan Syali billed 86,972 services in 225 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 24,000 | 23 | $0.88 | $21K |
| J1756 Injection, iron sucrose, 1 mg | Office | 8,000 | 27 | $0.18 | $1,412 |
| 85025 Blood Count | Office | 2,149 | 645 | $7.58 | $16K |
| 36415 Venipuncture Blood Collection | Office | 2,133 | 647 | $8.64 | $18K |
| 88185 Surgical Pathology Examination | Office | 1,845 | 71 | $22.14 | $41K |
| 80053 Clinical Chemistry | Office | 1,783 | 592 | $10.32 | $18K |
| 84100 Clinical Chemistry | Office | 1,526 | 544 | $4.63 | $7,073 |
| 83735 Clinical Chemistry | Office | 1,523 | 538 | $6.54 | $9,968 |
| 84550 Clinical Chemistry | Office | 1,454 | 529 | $4.41 | $6,419 |
| 83615 Clinical Chemistry | Office | 1,452 | 530 | $5.90 | $8,566 |
| 99214 Office E&M - Established | Office | 1,303 | 513 | $108.19 | $141K |
| 82784 Immunoassay | Office | 1,215 | 215 | $9.09 | $11K |
| 82728 Clinical Chemistry | Office | 1,155 | 490 | $13.30 | $15K |
| 83540 Clinical Chemistry | Office | 1,153 | 490 | $6.31 | $7,280 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,046 | 210 | $52.54 | $55K |
By year: 2022 $3.8M for 355,819 services; 2023 $1.8M for 162,161 services; 2024 $1.0M for 86,972 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,149 | 645 | $7.58 | $16K |
| 36415 Venipuncture Blood Collection | 2,133 | 647 | $8.64 | $18K |
| 88185 Surgical Pathology Examination | 1,845 | 71 | $22.14 | $41K |
| 80053 Clinical Chemistry | 1,783 | 592 | $10.32 | $18K |
| 84100 Clinical Chemistry | 1,526 | 544 | $4.63 | $7,073 |
| 83735 Clinical Chemistry | 1,523 | 538 | $6.54 | $9,968 |
| 84550 Clinical Chemistry | 1,454 | 529 | $4.41 | $6,419 |
| 83615 Clinical Chemistry | 1,452 | 530 | $5.90 | $8,566 |
| 82784 Immunoassay | 1,215 | 215 | $9.09 | $11K |
| 82728 Clinical Chemistry | 1,155 | 490 | $13.30 | $15K |
Medicare prescription drug claims, 2024
In 2024, the drug Gurmohan Syali prescribed most often to Medicare patients was Anastrozole, with 198 prescriptions and refills. In total Gurmohan Syali wrote 2,289 Medicare prescriptions that cost $8.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 198 | 376 | 47 | $2,946 |
| Aranesp Darbepoetin Alfa In Polysorbat | 166 | 166 | 36 | $606K |
| Akynzeo Fosnetupitant/Palonosetron | 107 | 107 | 24 | $125K |
| Xgeva Denosumab | 83 | 85 | 17 | $259K |
| Eliquis Apixaban | 74 | 103 | 15 | $58K |
| Ibrance Palbociclib | 72 | 72 | Under 11 | $1.1M |
| Xarelto Rivaroxaban | 60 | 94 | 18 | $51K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 57 | 60 | Under 11 | $438K |
| Pantoprazole Sodium Generic | 50 | 90 | 22 | $724 |
| Warfarin Sodium Generic | 49 | 89 | Under 11 | $728 |
| Duloxetine Hcl Generic | 49 | 93 | 13 | $1,467 |
| Potassium Chloride Generic | 44 | 44 | 23 | $61.63 |
| Somatuline Depot Lanreotide Acetate | 44 | 44 | Under 11 | $390K |
| Acyclovir Generic | 43 | 72 | Under 11 | $659 |
| Neulasta Onpro Pegfilgrastim | 43 | 43 | 11 | $255K |
Brand drugs: 1,227 claims; generic drugs: 1,062 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gurmohan Syali $128 ($128 in general payments such as food, travel and fees) from 3 companies. The largest payer was Menarini Silicon Biosystems, Inc. with $46.86.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.